Experts in expanded access programs gave a glimpse of the difficulties in getting investigational drugs to patients, from helping physicians navigate the process to budgeting funds to pay for the programs.
They discussed their experiences at a meeting held recently by the New York University Grossman School of Medicine Working Group...